# Cohort Study for Patients Using Fuzeon (Enfuvirtide)

> **NCT00216359** · — · UNKNOWN · sponsor: **Institute for Interdisciplinary Infectiology** · enrollment: 200 (—)

## Conditions studied

- HIV Infections
- Antiretroviral Treatment

## Interventions

- **DRUG:** Fuzeon (Enfuvirtide)
- **PROCEDURE:** Laboratory diagnostic (CD4-cells)
- **PROCEDURE:** Laboratory diagnostics (HIV-1 viral load)
- **DRUG:** antiretroviral co-medication beside Fuzeon

## Key facts

- **NCT ID:** NCT00216359
- **Lead sponsor:** Institute for Interdisciplinary Infectiology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 200 (—)
- **Last updated:** 2005-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216359, "Cohort Study for Patients Using Fuzeon (Enfuvirtide)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00216359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*